@article{76009ee0c0bc413aa3ce52909ba0e21c,
title = "Frequent-relapsing, steroid-dependent minimal change disease: Is rituximab the answer?",
keywords = "minimal change disease, nephrotic syndrome, relapses, rituximab, steroid",
author = "Fervenza, {Fernando C.} and Sanjeev Sethi",
note = "Funding Information: F.C.F. and S.S would like to thank the Fulk Family Foundation for its research support. Funding Information: F.C.F. has received unrestricted research grants from Genen-tech, Inc., the manufacturer of rituximab.",
year = "2014",
month = apr,
doi = "10.1093/ndt/gft366",
language = "English (US)",
volume = "29",
pages = "722--727",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "4",
}